Castleark Management LLC Amicus Therapeutics, Inc. Transaction History

Castleark Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$9.2 - $23.86 $2.4 Million - $6.22 Million	-260,700 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$13.47 - $24.89 $1.44 Million - $2.66 Million	-107,005 Reduced 29.1%	260,700 $6.02 Million
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $4.74 Million - $5.84 Million	367,705 New	367,705 $5.19 Million
Q2 2019 Aug 13, 2019	SELL	$10.96 - $14.4 $4.84 Million - $6.36 Million	-441,674 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$10.04 - $13.92 $4.43 Million - $6.15 Million	441,674 New	441,674 $6.01 Million

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.64B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.